AG-024322 is a potent and selective multi-targeted CDK inhibitor with broad spectrum anti-proliferative activity
Year: 2005
Type: article
Source: Cancer Research
Authors: Cathy C. Zhang, Susan E. Kephart, Indrawan McAlpine, Jim Nonomiya, Joseph R. Higgins, Maria E. Arango, Zhengming Yan, Daniel Knighton, Rose Ann Ferre, Jayashree Tikhe, Gennady M. Verkhivker, Meirong Xu, William H. Romines, Cindy Palmer, Julie Park, Siegfried Reich, Wes Chong, Lin Li, Gerrit Los, Cristina Lewis
Institution: Pfizer (United States)
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2326310410
